Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NON-NMDA ANTAGONISTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Madsen, U; Stensbol, TB; Krogsgaard-Larsen, P
      Inhibitors of AMPA and kainate receptors

      CURRENT MEDICINAL CHEMISTRY
    2. Szabados, T; Gigler, G; Gacsalyi, I; Gyertyan, I; Levay, G
      Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655

      BRAIN RESEARCH BULLETIN
    3. Abraham, G; Solyom, S; Csuzdi, E; Berzsenyi, P; Ling, I; Tarnawa, I; Hamori, T; Pallagi, I; Horvath, K; Andrasi, F; Kapus, G; Harsing, LG; Kiraly, I; Patthy, M; Horvath, G
      New non competitive AMPA antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    4. Barna, B; Szasz, A; Vilagi, I; Szente, M
      Anticonvulsive effect of AMPA receptor antagonist GYKI 52466 on 4-aminopyridine-induced cortical ictal activity in rat

      BRAIN RESEARCH BULLETIN
    5. Hantzschel, A; Andreas, K
      Non-N-methyl-D-aspartate (NMDA) receptor antagonist 1,2,3,4-tetra-hydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulphonamide (NBQX) decreases functional disorders in cytotoxic brain oedema

      ARCHIVES OF TOXICOLOGY
    6. Marinelli, S; Gatta, F; Sagratella, S
      Effects of GYKI 52466 and some 2,3-benzodiazepine derivatives on hippocampal in vitro basal neuronal excitability and 4-aminopyridine epileptic activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Chi, OZ; Chang, Q; Wang, GL; Liu, X; Weiss, HR
      A nonNMDA antagonist, GYKI52466 improves microscopic O-2 balance in the cortex during focal cerebral ischemia

      NEUROLOGICAL RESEARCH
    8. Pouw, B; Nour, M; Matsumoto, RR
      Effects of AMPA/kainate glutamate receptor antagonists on cocaine-induced convulsions and lethality in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    9. De Sarro, G; Di Paola, ED; Gareri, P; Gallelli, L; Scotto, G; De Sarro, A
      Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Urbanska, EM; Czuczwar, SJ; Kleinrok, Z; Turski, WA
      Excitatory amino acids in epilepsy

      RESTORATIVE NEUROLOGY AND NEUROSCIENCE
    11. FILLIAT P; PERNOTMARINO I; BAUBICHON D; LALLEMENT G
      BEHAVIORAL-EFFECTS OF NBQX, A COMPETITIVE ANTAGONIST OF THE AMPA RECEPTORS

      Pharmacology, biochemistry and behavior
    12. Tauboll, E; Gjerstad, L
      Effects of antiepileptic drugs on the activation of glutamate receptors

      GLUTAMATE SYNAPSE AS A THERAPEUTICAL TARGET: MOLECULAR ORGANIZATION AND PATHOLOGY OF THE GLUTAMATE SYNAPSE
    13. SIMMONS RMA; LI DL; HOO KH; DEVERILL M; ORNSTEIN PL; IYENGAR S
      KAINATE GLUR5 RECEPTOR SUBTYPE MEDIATES THE NOCICEPTIVE RESPONSE TO FORMALIN IN THE RAT

      Neuropharmacology
    14. LIU XH; WANG P; BARKS JDE
      THE NONCOMPETITIVE AMPA ANTAGONIST LY-300168 (GYKI-53655) ATTENUATES AMPA-INDUCED HIPPOCAMPAL INJURY IN NEONATAL RODENTS

      Neuroscience letters
    15. MARES P; MIKULECKA A; POMETLOVA M
      ANTICONVULSAN ACTION OF -DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE IN IMMATURE WATS - COMPARISON WITH THE EFFECTS ON MOTOR-PERFORMANCE

      The Journal of pharmacology and experimental therapeutics
    16. DURMULLER N; GRAHAM JL; SOWINSKI P; MELDRUM BS
      THE VITAL DYE EVANS BLUE MIMICS LIMBIC SEIZURES INDUCED BY KAINATE ORPILOCARPINE

      Brain research
    17. LODGE D; BOND A; ONEILL MJ; HICKS CA; JONES MG
      STEREOSELECTIVE EFFECTS OF 2,3-BENZODIAZEPINES IN-VIVO - ELECTROPHYSIOLOGY AND NEUROPROTECTION STUDIES

      Neuropharmacology
    18. BLOCK F; SCHMITT W; SCHWARZ M
      PRETREATMENT BUT NOT POSTTREATMENT WITH GYKI-52466 REDUCES FUNCTIONALDEFICITS AND NEURONAL DAMAGE AFTER GLOBAL-ISCHEMIA IN RATS

      Journal of the neurological sciences
    19. RAMMES G; SWANDULLA D; COLLINGRIDGE GL; HARTMANN S; PARSONS CG
      INTERACTIONS OF 2,3-BENZODIAZEPINES AND CYCLOTHIAZIDE AT AMPA RECEPTORS - PATCH-CLAMP RECORDINGS IN CULTURED NEURONS AND AREA CA1 IN HIPPOCAMPAL SLICES

      British Journal of Pharmacology
    20. LEES GJ; LEONG W
      SYNERGY BETWEEN DIAZEPAM AND NBQX IN PREVENTING NEURONAL DEATH CAUSEDBY NON-NMDA AGONISTS

      NeuroReport
    21. LEES GJ; LEONG W
      NBQX PREVENTS CONTRALATERAL BUT NOT IPSILATERAL SEIZURE-INDUCED CYTOTOXICITY OF KAINATE BUT NOT AMPA-REVERSAL AT HIGH-DOSES OF NBQX

      NeuroReport
    22. DURMULLER N; CRAGGS M; MELDRUM BS
      THE EFFECT OF THE NON-NMDA RECEPTOR ANTAGONISTS GYKI-52466 AND NBQX AND THE COMPETITIVE NMDA RECEPTOR ANTAGONIST D-CPPENE ON THE DEVELOPMENT OF AMYGDALA KINDLING AND ON AMYGDALA-KINDLED SEIZURES

      Epilepsy research
    23. MASSIEU L; TAPIA R
      -DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE PROTECTS AGAINST BOTH AMPA AND KAINATE-INDUCED LESIONS IN RAT STRIATUM IN-VIVO

      Neuroscience
    24. TOTH S; TARNAWA I; PENZES I; SARMANY J; TOTH Z
      AGE-DEPENDENT MODIFICATION OF ASPECIFIC CELLULAR EFFECTS OF THE BENZODIAZEPINE FLUNITRAZEPAM

      Archives of gerontology and geriatrics
    25. PARSONS CG; CRUNER R; ROZENTAL J
      COMPARATIVE PATCH-CLAMP STUDIES ON THE KINETICS AND SELECTIVITY OF GLUTAMATE-RECEPTOR ANTAGONISM BY -DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE (NBQX) AND -4-METHYL-7,8-METHYLENDIOXYL-5H-2,3-BENZODIAZEPINE (GYKI-52466)

      Neuropharmacology
    26. MELDRUM BS
      THE ROLE OF GLUTAMATE IN EPILEPSY AND OTHER CNS DISORDERS

      Neurology
    27. DONEVAN SD; YAMAGUCHI S; ROGAWSKI MA
      NON-N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISM BY 3-N-SUBSTITUTED 2,3-BENZODIAZEPINES - RELATIONSHIP TO ANTICONVULSANT ACTIVITY

      The Journal of pharmacology and experimental therapeutics
    28. GASPARY HL; SIMON RP; GRAHAM SH
      BW1003C87 AND NBQX BUT NOT CGS19755 REDUCE GLUTAMATE RELEASE AND CEREBRAL ISCHEMIC NECROSIS

      European journal of pharmacology
    29. MULLER TB; HARALDSETH O; SONNEWALD U; UNSGARD G; PETERSEN SB
      NBQX DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE) DID NOT AFFECT RECOVERY OF HIGH-ENERGY PHOSPHATES AND PH IN EARLY REPERFUSION IN A RAT MODEL OF TRANSIENT FOREBRAIN ISCHEMIA OR - AN IN-VIVO P-31 NMR-SPECTROSCOPY STUDY

      Acta anaesthesiologica Scandinavica
    30. YAMAGUCHI S; DONEVAN SD; ROGAWSKI MA
      ANTICONVULSANT ACTIVITY OF AMPA KAINATE ANTAGONISTS - COMPARISON OF GYKI 52466 AND NBQX IN MAXIMAL ELECTROSHOCK AND CHEMOCONVULSANT SEIZUREMODELS

      Epilepsy research
    31. ORNSTEIN PL; ARNOLD MB; AUGENSTEIN NK; LODGE D; LEANDER JD; SCHOEPP DD
      AZOL-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID - A STRUCTURALLY NOVEL, SYSTEMICALLY ACTIVE, COMPETITIVE AMPA RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    32. LEES GJ; LEONG W
      DIFFERENTIAL-EFFECTS OF NBQX ON THE DISTAL AND LOCAL TOXICITY OF GLUTAMATE AGONISTS ADMINISTERED INTRA-HIPPOCAMPALLY

      Brain research
    33. ROGAWSKI MA
      THERAPEUTIC POTENTIAL OF EXCITATORY AMINO-ACID ANTAGONISTS - CHANNEL BLOCKERS AND 2,3-BENZODIAZEPINES

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 09:52:34